This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
While medicalscience advances, too many clinics still rely on cumbersome paperwork. For too long, the administrative side of healthcare has lagged behind its clinical advancements. Once prescribed the medication, you can include questions about weight loss and sideeffects to assess progress and make necessary adjustments.
Nearly half of oncologists, including hematology-oncologists and medical oncologists, allude to treatment challenges including sideeffects and patient comorbidities, and seek out medical information to address these challenges. In contrast, half of U.S. While only one third of U.S.
About the interviewee Imran Khan, MD, PhD is Vice President Medical Affairs, Hematology at Johnson & Johnson Innovative Medicine. Most recently, Imran has served as MedicalScience Liaison (MSL) Head, Oncology U.S. Medical Affairs. CAR T-cell Therapy and its sideeffects [Internet]. Cancer.gov.
Medicalscience Liaisons know that change is coming; How are they cashing in? Medicalscience liaisons (MSLs) within pharmaceutical companies deal in a special currency: scientific exchange and real-world insights gathering.
.” An attractive proposition in a world in which technology has contributed significantly to the distancing of physicians from their patients, usually leading to negative sideeffects. Hundreds of Israeli life science firms will be showing off their products and technologies to attendees from all over the world.
This means that during the Q&A session, you may face a myriad of intricate medical, functional, or operational questions. A MedicalScience Liaison’s job is to build relationships, so distinguishing yourself in these ways is paramount. For a MedicalScience Liaison, having medical knowledge is a given necessity.
BTKis, oral drugs given as continuous monotherapy, have revolutionised the treatment of CLL, with the first generation BTKi ibrutinib receiving European Medicines Agency (EMA) approval in 2014; however, side-effects (such as cardiovascular toxicities 2 ) have limited its suitability.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content